View our masking and visitation guidelines based on current rates of respiratory illnesses in the community.

Our new building on the hospital campus, Forest B, is open. Families and visitors can park in the new Forest B garage next to Emergency.

Clinical Trial Search block Test

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Human Allogeneic Cardiosphere-Derived Cells for The Treatment of Duchenne Muscular Dystrophy

Capricor Hope-3 study

Condition(s): Other
Phase: III

What is the goal of the study?

The purpose of the clinical trial is to assess the efficacy and safety of the investigational product (IP), CAP-1002, administered every 3 months by IV infusion in subjects with Duchenne muscular dystrophy and impaired skeletal muscle function.

Who can participate in the study?

Everyone

Study Team:

PI (Study Doctor): Seth Perlman
Study Team Member: Richard Torres, richard.torres@seattlechildrens.org